Tandem Diabetes Care Company Profile (NASDAQ:TNDM)

About Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care logoTandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: N/A
  • Symbol: NASDAQ:TNDM
  • CUSIP: N/A
  • Web: www.tandemdiabetes.com
Capitalization:
  • Market Cap: $30.3 million
  • Outstanding Shares: 50,228,000
Average Prices:
  • 50 Day Moving Avg: $0.62
  • 200 Day Moving Avg: $0.92
  • 52 Week Range: $0.39 - $8.81
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.56
  • P/E Growth: -0.01000
Sales & Book Value:
  • Annual Revenue: $81.51 million
  • Price / Sales: 0.35
  • Book Value: ($0.36) per share
  • Price / Book: -1.57
Profitability:
  • EBIDTA: ($76,170,000.00)
  • Net Margins: -110.70%
  • Return on Equity: -1,177.11%
  • Return on Assets: -87.18%
Debt:
  • Debt-to-Equity Ratio: -4.09%
  • Current Ratio: 2.11%
  • Quick Ratio: 1.28%
Misc:
  • Average Volume: 1.30 million shs.
  • Beta: 0.36
  • Short Ratio: 3.34
 

Frequently Asked Questions for Tandem Diabetes Care (NASDAQ:TNDM)

What is Tandem Diabetes Care's stock symbol?

Tandem Diabetes Care trades on the NASDAQ under the ticker symbol "TNDM."

How were Tandem Diabetes Care's earnings last quarter?

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) released its quarterly earnings results on Thursday, July, 27th. The company reported ($0.44) EPS for the quarter, beating analysts' consensus estimates of ($0.48) by $0.04. The company earned $21.30 million during the quarter, compared to analysts' expectations of $21.74 million. Tandem Diabetes Care had a negative return on equity of 1,177.11% and a negative net margin of 110.70%. The firm's revenue was down 7.4% compared to the same quarter last year. During the same period last year, the business posted ($0.60) earnings per share. View Tandem Diabetes Care's Earnings History.

When will Tandem Diabetes Care make its next earnings announcement?

Tandem Diabetes Care is scheduled to release their next quarterly earnings announcement on Monday, October, 30th 2017. View Earnings Estimates for Tandem Diabetes Care.

Where is Tandem Diabetes Care's stock going? Where will Tandem Diabetes Care's stock price be in 2017?

9 brokers have issued 1-year price targets for Tandem Diabetes Care's stock. Their predictions range from $1.50 to $11.00. On average, they expect Tandem Diabetes Care's share price to reach $5.08 in the next twelve months. View Analyst Ratings for Tandem Diabetes Care.

Are investors shorting Tandem Diabetes Care?

Tandem Diabetes Care saw a increase in short interest during the month of August. As of August 15th, there was short interest totalling 2,305,655 shares, an increase of 41.1% from the July 31st total of 1,634,155 shares. Based on an average trading volume of 715,813 shares, the days-to-cover ratio is presently 3.2 days. Approximately 6.3% of the company's shares are sold short.

Who are some of Tandem Diabetes Care's key competitors?

Who are Tandem Diabetes Care's key executives?

Tandem Diabetes Care's management team includes the folowing people:

  • Dick P. Allen, Chairman of the Board
  • Kim D. Blickenstaff, President, Chief Executive Officer, Board Member
  • John Cajigas, Chief Financial Officer, Treasurer
  • John F. Sheridan, Chief Operating Officer, Executive Vice President
  • Brian Hansen, Chief Commercial Officer, Executive Vice President
  • Susan M. Morrison, Chief Administrative Officer
  • Lori Gildea, Vice President - Sales
  • David B. Berger Esq., General Counsel, Corporate Secretary
  • Edward L. Cahill, Independent Director
  • Fred E. Cohen Ph.D. M.D., Independent Director

Who owns Tandem Diabetes Care stock?

Tandem Diabetes Care's stock is owned by many different of institutional and retail investors. Top institutional investors include Frontier Capital Management Co. LLC (9.76%), Wasatch Advisors Inc. (6.32%), TPG Group Holdings SBS Advisors Inc. (4.97%), Vanguard Group Inc. (2.46%), DAFNA Capital Management LLC (1.44%) and Russell Investments Group Ltd. (1.17%). Company insiders that own Tandem Diabetes Care stock include Dick Allen, John F Sheridan and Kim D Blickenstaff. View Institutional Ownership Trends for Tandem Diabetes Care.

Who sold Tandem Diabetes Care stock? Who is selling Tandem Diabetes Care stock?

Tandem Diabetes Care's stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc. and Shaker Investments LLC OH. View Insider Buying and Selling for Tandem Diabetes Care.

Who bought Tandem Diabetes Care stock? Who is buying Tandem Diabetes Care stock?

Tandem Diabetes Care's stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Keybank National Association OH, Vanguard Group Inc., Frontier Capital Management Co. LLC and Falcon Point Capital LLC. Company insiders that have bought Tandem Diabetes Care stock in the last two years include Dick Allen and Kim D Blickenstaff. View Insider Buying and Selling for Tandem Diabetes Care.

How do I buy Tandem Diabetes Care stock?

Shares of Tandem Diabetes Care can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tandem Diabetes Care's stock price today?

One share of Tandem Diabetes Care stock can currently be purchased for approximately $0.57.


MarketBeat Community Rating for Tandem Diabetes Care (NASDAQ TNDM)
Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  138 (Vote Outperform)
Underperform Votes:  153 (Vote Underperform)
Total Votes:  291
MarketBeat's community ratings are surveys of what our community members think about Tandem Diabetes Care and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Tandem Diabetes Care (NASDAQ:TNDM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 5 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.44)
Consensus Price Target: $5.08 (791.66% upside)

Analysts' Ratings History for Tandem Diabetes Care (NASDAQ:TNDM)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/3/2017B. RileyReiterated RatingNeutral$1.50MediumView Rating Details
4/10/2017Cowen and CompanyDowngradeOutperform -> Market Perform$1.50MediumView Rating Details
3/30/2017WedbushReiterated RatingOutperform$11.00LowView Rating Details
3/30/2017Piper Jaffray CompaniesReiterated RatingNeutral -> NeutralMediumView Rating Details
3/9/2017Northcoast ResearchReiterated RatingBuyN/AView Rating Details
11/2/2016Deutsche Bank AGLower Price TargetBuy$14.00 -> $9.00N/AView Rating Details
11/2/2016Feltl & Co.DowngradeStrong-Buy -> BuyN/AView Rating Details
11/2/2016Robert W. BairdDowngradeOutperform -> Neutral$11.00 -> $4.00N/AView Rating Details
11/2/2016Stifel NicolausDowngradeBuy -> Hold$15.00 -> $3.50N/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingNeutralN/AView Rating Details
3/24/2016Bank of America CorporationDowngradeNeutral -> UnderperformN/AView Rating Details
10/21/2015William BlairReiterated RatingMarket PerformN/AView Rating Details
(Data available from 9/20/2015 forward)

Earnings

Earnings History for Tandem Diabetes Care (NASDAQ:TNDM)
Earnings by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)
Earnings History by Quarter for Tandem Diabetes Care (NASDAQ TNDM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/30/2017($0.44)N/AView Earnings Details
7/27/2017Q2 2017($0.48)($0.44)$21.74 million$21.30 millionViewN/AView Earnings Details
4/27/2017Q1 2017($0.66)($0.75)$15.72 million$17.50 millionViewN/AView Earnings Details
3/8/2017Q4 2016($0.65)($0.48)$22.75 million$24.80 millionViewListenView Earnings Details
7/28/2016Q216($0.65)($0.60)$23.08 million$23.00 millionViewListenView Earnings Details
4/28/2016Q116($0.69)($0.68)$17.67 million$20.06 millionViewN/AView Earnings Details
2/24/2016Q415($0.51)($0.40)$29.17 million$29.10 millionViewListenView Earnings Details
10/29/2015Q3($0.80)($0.65)$12.58 million$15.70 millionViewListenView Earnings Details
7/30/2015Q215($0.71)($0.65)$14.92 million$15.70 millionViewListenView Earnings Details
4/30/2015Q115($0.79)($0.83)$12.19 million$12.30 millionViewN/AView Earnings Details
2/24/2015Q414($0.81)($0.78)$17.16 million$17.90 millionViewN/AView Earnings Details
11/6/2014Q314($0.82)($0.85)$13.60 million$13.50 millionViewN/AView Earnings Details
7/31/2014Q214($0.91)($0.83)$10.36 million$10.26 millionViewN/AView Earnings Details
5/6/2014Q1($0.69)($0.96)$8.24 million$8.10 millionViewN/AView Earnings Details
11/8/2011$0.25$0.18ViewN/AView Earnings Details
8/9/2011$0.26$0.20ViewN/AView Earnings Details
5/10/2011$0.24$0.24ViewN/AView Earnings Details
3/14/2011$0.29$0.18ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Tandem Diabetes Care (NASDAQ:TNDM)
2017 EPS Consensus Estimate: ($1.79)
2018 EPS Consensus Estimate: ($1.17)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175($0.81)($0.62)($0.71)
Q2 20174($0.63)($0.37)($0.46)
Q3 20174($0.50)($0.33)($0.38)
Q4 20175($0.28)($0.21)($0.25)
Q1 20182($0.34)($0.34)($0.34)
Q2 20182($0.34)($0.28)($0.31)
Q3 20182($0.28)($0.28)($0.28)
Q4 20182($0.28)($0.20)($0.24)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Tandem Diabetes Care (NASDAQ:TNDM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Tandem Diabetes Care (NASDAQ:TNDM)
Insider Ownership Percentage: 20.90%
Institutional Ownership Percentage: 36.64%
Insider Trades by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)
Institutional Ownership by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)
Insider Trades by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/23/2017Kim D BlickenstaffCEOBuy1,600,000$1.25$2,000,000.00View SEC Filing  
8/1/2016John F SheridanEVPSell15,000$6.52$97,800.00View SEC Filing  
5/2/2016John F SheridanCOOSell2,000$10.61$21,220.00View SEC Filing  
4/22/2016John F SheridanCOOSell2,000$10.00$20,000.00View SEC Filing  
3/7/2016John F SheridanCOOSell4,000$10.01$40,040.00View SEC Filing  
2/26/2016Dick AllenDirectorBuy10,000$8.24$82,400.00View SEC Filing  
12/1/2015John F. SheridanCOOSell2,000$10.14$20,280.00View SEC Filing  
11/2/2015John F. SheridanCOOSell4,000$10.00$40,000.00View SEC Filing  
9/14/2015John F. SheridanCOOSell2,000$12.51$25,020.00View SEC Filing  
5/1/2015John F SheridanCOOSell2,000$13.72$27,440.00View SEC Filing  
4/1/2015John F SheridanCOOSell2,000$12.47$24,940.00View SEC Filing  
2/2/2015John F SheridanCOOSell2,000$12.06$24,120.00View SEC Filing  
1/2/2015John F SheridanCOOSell2,000$12.75$25,500.00View SEC Filing  
12/12/2014Dick AllenDirectorBuy10,000$11.95$119,500.00View SEC Filing  
12/1/2014John F SheridanCOOSell2,000$13.55$27,100.00View SEC Filing  
11/3/2014John F SheridanCOOSell2,000$16.00$32,000.00View SEC Filing  
10/1/2014John F SheridanCOOSell2,000$13.07$26,140.00View SEC Filing  
9/2/2014John F SheridanCOOSell2,000$13.99$27,980.00View SEC Filing  
8/1/2014John F SheridanCOOSell2,000$15.04$30,080.00View SEC Filing  
7/1/2014John F SheridanCOOSell2,000$16.42$32,840.00View SEC Filing  
6/18/2014John F SheridanCOOSell2,000$16.75$33,500.00View SEC Filing  
11/13/2013David B BergerGeneral CounselBuy2,000$15.00$30,000.00View SEC Filing  
11/13/2013Hlm Venture Partners Ii, L.P.Major ShareholderBuy200,000$15.00$3,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Tandem Diabetes Care (NASDAQ:TNDM)
Latest Headlines for Tandem Diabetes Care (NASDAQ:TNDM)
Source:
DateHeadline
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Tandem Diabetes Care, Inc.
finance.yahoo.com - September 8 at 9:20 AM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) Expected to Post Quarterly Sales of $26.07 Million
www.americanbankingnews.com - September 6 at 1:28 PM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - September 5 at 8:54 AM
finance.yahoo.com logoETFs with exposure to Tandem Diabetes Care, Inc. : September 1, 2017
finance.yahoo.com - September 1 at 9:55 AM
reuters.com logoBRIEF-Tandem Diabetes Care announces FDA approval, launch of t:slim X2 insulin pump with Dexcom G5 mobile CGM integration
www.reuters.com - August 30 at 10:17 AM
finance.yahoo.com logoTandem Diabetes Care Announces FDA Approval and Launch of t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM Integration
finance.yahoo.com - August 29 at 8:47 AM
finance.yahoo.com logoToday's Research Reports on Trending Tickers: Gilead Sciences Inc. and Tandem Diabetes Care Inc.
finance.yahoo.com - August 29 at 8:46 AM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) Short Interest Update
www.americanbankingnews.com - August 28 at 1:20 AM
streetinsider.com logoTandem Diabetes (TNDM) Granted Patent for Remote Bolus Feature on Medical Infusion Pumps
www.streetinsider.com - August 25 at 1:13 AM
seekingalpha.com logoTandem Diabetes awarded new U.S. patent covering insulin pump; shares ahead 4% after hours
seekingalpha.com - August 24 at 8:11 PM
finance.yahoo.com logoTandem Diabetes Care Announces Issuance of Patent Related to Remote Bolus Feature for Medical Infusion Pumps
finance.yahoo.com - August 24 at 8:11 PM
finance.yahoo.com logoTandem Diabetes Care Announces Launch of t:lock Connector for its Insulin Pump Cartridges and Infusion Sets
finance.yahoo.com - August 23 at 12:39 PM
americanbankingnews.com logoCritical Contrast: Exactech (EXAC) and Tandem Diabetes Care (TNDM)
www.americanbankingnews.com - August 21 at 2:24 PM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) Expected to Post Quarterly Sales of $26.16 Million
www.americanbankingnews.com - August 18 at 9:42 AM
americanbankingnews.com logoTandem Diabetes Care Inc (TNDM) Expected to Post Earnings of -$0.44 Per Share
www.americanbankingnews.com - August 16 at 4:32 PM
finance.yahoo.com logoTandem Diabetes Care Begins Enrollment in Pivotal Trial for First Touchscreen Insulin Pump with Predictive Low Glucose Suspend (PLGS)
finance.yahoo.com - August 16 at 8:17 AM
americanbankingnews.com logoInvacare Corporation (IVC) versus Tandem Diabetes Care (TNDM) Financial Review
www.americanbankingnews.com - August 15 at 11:10 AM
finance.yahoo.com logoETFs with exposure to Tandem Diabetes Care, Inc. : August 14, 2017
finance.yahoo.com - August 15 at 7:46 AM
americanbankingnews.com logoTandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - August 11 at 5:06 PM
seekingalpha.com logoTandem Diabetes nabs U.S. patent related to portable infusion pump safety features; shares ahead 2%
seekingalpha.com - August 9 at 8:17 AM
finance.yahoo.com logoTandem Diabetes Care Announces Issuance of Patent Related to Important Safety Features for Portable Infusion Pumps that Utilize Touchscreen Control
finance.yahoo.com - August 9 at 8:17 AM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - August 2 at 8:32 AM
prnewswire.com logoMedical Supplies Stock Performance Review -- Tandem Diabetes Care, Merit ...
www.prnewswire.com - August 2 at 7:54 AM
businesswire.com logoTandem Diabetes Care to Present at the 2017 Wedbush PacGrow Healthcare Conference
www.businesswire.com - August 2 at 7:54 AM
finance.yahoo.com logoTandem Diabetes Care, Inc. :TNDM-US: Earnings Analysis: Q2, 2017 By the Numbers : July 31, 2017
finance.yahoo.com - August 1 at 6:58 AM
americanbankingnews.com logo$26.59 Million in Sales Expected for Tandem Diabetes Care, Inc. (NASDAQ:TNDM) This Quarter
www.americanbankingnews.com - July 31 at 9:33 AM
americanbankingnews.com logo Analysts Expect Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Will Announce Earnings of -$0.45 Per Share
www.americanbankingnews.com - July 29 at 10:08 AM
finance.yahoo.com logoEdited Transcript of TNDM earnings conference call or presentation 27-Jul-17 8:30pm GMT
finance.yahoo.com - July 29 at 7:58 AM
seekingalpha.com logoTandem Diabetes Care's (TNDM) CEO Kim Blickenstaff on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - July 28 at 8:52 AM
finance.yahoo.com logoTandem Diabetes Care Reports Second Quarter 2017 Financial Results
finance.yahoo.com - July 28 at 8:52 AM
americanbankingnews.com logoTandem Diabetes Care, Inc. (NASDAQ:TNDM) Announces Earnings Results
www.americanbankingnews.com - July 27 at 9:08 PM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - July 19 at 8:52 AM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - July 17 at 10:54 AM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) Short Interest Down 35.3% in June
www.americanbankingnews.com - July 17 at 7:24 AM
finance.yahoo.com logoTandem Diabetes Care Schedules Second Quarter 2017 Earnings Press Release and Conference Call
finance.yahoo.com - July 14 at 9:18 AM
finance.yahoo.com logoETFs with exposure to Tandem Diabetes Care, Inc. : July 13, 2017
finance.yahoo.com - July 14 at 9:18 AM
americanbankingnews.com logoZacks: Analysts Anticipate Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Will Announce Quarterly Sales of $21.83 Million
www.americanbankingnews.com - July 7 at 2:42 PM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) Expected to Post Earnings of -$0.48 Per Share
www.americanbankingnews.com - July 5 at 9:50 AM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - June 20 at 8:34 AM
finance.yahoo.com logoTandem Diabetes Care Presents Findings from Predictive Low Glucose Suspend (PLGS) Feasibility Study and Announces Approval of Investigational Device Exemption (IDE) for Pivotal Trial
finance.yahoo.com - June 12 at 7:43 PM
americanbankingnews.com logo$21.83 Million in Sales Expected for Tandem Diabetes Care Inc (TNDM) This Quarter
www.americanbankingnews.com - June 11 at 10:02 AM
americanbankingnews.com logo Analysts Expect Tandem Diabetes Care Inc (TNDM) to Announce -$0.49 EPS
www.americanbankingnews.com - June 9 at 7:40 AM
americanbankingnews.com logoTandem Diabetes Care Inc (TNDM) Short Interest Up 14.4% in May
www.americanbankingnews.com - June 5 at 8:40 AM
finance.yahoo.com logoETFs with exposure to Tandem Diabetes Care, Inc. : June 2, 2017
finance.yahoo.com - June 2 at 3:28 PM
americanbankingnews.com logoTandem Diabetes Care Inc (TNDM) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - May 26 at 8:51 AM
finance.yahoo.com logoETFs with exposure to Tandem Diabetes Care, Inc. : May 19, 2017
finance.yahoo.com - May 19 at 6:14 PM
americanbankingnews.com logoTandem Diabetes Care Inc (TNDM) Expected to Announce Quarterly Sales of $21.83 Million
www.americanbankingnews.com - May 14 at 8:45 AM
americanbankingnews.com logo-$0.49 EPS Expected for Tandem Diabetes Care Inc (TNDM) This Quarter
www.americanbankingnews.com - May 13 at 12:04 AM
finance.yahoo.com logoETFs with exposure to Tandem Diabetes Care, Inc. : May 8, 2017
finance.yahoo.com - May 8 at 7:45 PM
americanbankingnews.com logoSomewhat Positive Media Coverage Somewhat Likely to Impact Tandem Diabetes Care (TNDM) Stock Price
www.americanbankingnews.com - May 3 at 8:36 PM

Social

Chart

Tandem Diabetes Care (TNDM) Chart for Wednesday, September, 20, 2017

This page was last updated on 9/20/2017 by MarketBeat.com Staff